Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2024-02-20 to 2024-05-20
Current total value of award: $88949.64
Description: ORLADEYO EMERGENT